BCL2L1 and clear cell renal carcinoma: Moreover, increased expression of anti-apoptotic proteins (Bcl-2, Bcl-xL) and decreased pro-apoptotic protein (Bax and Bad) have been reported to be involved in the resistance of clear-cell renal cell carcinoma cells to imatinib [15].